Calidi Biotherapeutics (NYSE American: CLDI) has announced plans to sell shares of its common stock and/or pre-funded warrants in a <a target ...

Is a cure on the way? Quinn Peterson remains cautious—again, those living with diabetes have been promised a cure for decades ...

Brookfield Wealth Solutions today announced financial results for the quarter ended September 30, 2024. Sachin Shah, CEO, stated, "We generated strong returns in the quarter, led by $5 billion of ...

Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report) yesterday and set a ...

With a mission to drive equitable healthcare solutions and reshape the future of aging, the summit aims to establish Canada as a global leader in health optimization and the longevity economy.

In a report released today, Julian Harrison from BTIG maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report), with a ...

Detailed price information for Calidi Biotherapeutics Inc (CLDI-A) from The Globe and Mail including charting and trades.

Mullen Automotive, Inc. (NASDAQ: MULN) ("Mullen” or the "Company”), an electric vehicle ("EV”) manufacturer, announces today ...

Bronson.AI Joins the EDM Council to Expand Access to Global Best Practices in Data Management, Governance, and Analytics to ...

Pangaea Logistics Solutions Ltd (NASDAQ:PANL) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate ...